top of page

About
- Corporate Overview
- Executive Management
Science
- Limbic Stem Cells & Exosome
- DNA Methylation Analysis
Services
Pipeline
- Cancer Detection
- Eye Related
Social Responsibility
Newsroom
Contact
More

Use tab to navigate through the menu items.

Newsroom

All Posts
Publication
News

Taiwan’s Innovative Team Leads the World: EG BioMed’s Pancreatic Cancer Detection Technology Receives International Recognition.

Taiwan’s Innovative Team Leads the World: EG BioMed’s Pancreatic Cancer Detection Technology Receives International Recognition.

Taiwan’s Innovative Team Leads the World: EG BioMed’s Pancreatic Cancer Detection Technology Receives International Recognition.

Taipei – The R&D team at Taiwan’s EG BioMed Co. Ltd . has made significant progress in the field of pancreatic cancer detectio n, with...

May 24, 2024

Non-Invasive Precision Monitoring of Tumors and Early Cancer Detection Using Methylated Free DNA in Blood

Non-Invasive Precision Monitoring of Tumors and Early Cancer Detection Using Methylated Free DNA in Blood

Non-Invasive Precision Monitoring of Tumors and Early Cancer Detection Using Methylated Free DNA in Blood

Introducing the All-seeing Eye, a groundbreaking technology that detects methylated circulating cell-free DNA released from tumors...

Dec 31, 2023

Contact

17 F., No. 3, Yuanqu St., Nangang Dist.,

Taipei City 115603, Taiwan (R.O.C.)

Email: service@udn-pharm.com

Tel: +886-2-2382-0330

Menu

Products & Services

Social Responsibility

bottom of page